OpenAI’s cozy partner Cerebras is on track for a blockbuster IPO
AI chip maker Cerebras is heading for a blockbuster IPO that could value it at $26.6 billion or more. Its relationship with OpenAI is deep and rich.
Read on TechCrunch →Article discusses the application of AI solutions to address challenges in the healthcare sector.
Why it matters
This article highlights the significant potential of AI to revolutionize healthcare by tackling critical issues like cost, staffing, and patient care. By applying AI to diverse areas from diagnostics to operational efficiency, it promises to improve outcomes, reduce burdens on healthcare professionals, and make care more accessible and effective.
AI is being used to help doctors and hospitals. It can help find diseases, assist in surgeries, and make running a hospital easier, especially as more people get older and there aren't enough doctors.
AI chip maker Cerebras is heading for a blockbuster IPO that could value it at $26.6 billion or more. Its relationship with OpenAI is deep and rich.
Read on TechCrunch →Elon Musk's alleged texts to OpenAI executives Sam Altman and Greg Brockman, threatening they would be 'most hated men in America' if a settlement wasn't reached, are revealed amidst a lawsuit.
Read on TechCrunch →This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here. Two of the most powerful people in AI—Sam Altman and Elon Musk—began their face-off in court in Oakland, California, last week. Musk is suing OpenAI, alleging that the millions he spent to…
Read on MIT Technology Review →